Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (582)	7/19/1999 12:23:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 4474

(refresh) Cardiac hypertrophy --I just mean to post this for the thread Rick, and I appreciate your comments and reservations about management and the toxic. So I was surfing the web again today and found a paper in Cell, that mentions that disruption of NFATC1 results in defects in cardiac valve development... (Cell, Vol. 92, 687-696; March 6, '98) This took me over to the comment in the Ariad annual report about their license on patents regarding materials and methods for drug discovery efforts based on NF-AT targets. (see page 21 of the annual under Stanford.) Here is the Ariad PR on this: corporate-ir.net None of this is new...but it would be nice to hear in that mid-year letter to shareholders if there has been any developments in that area. Other interesting links are here: glviris.harvard.edu --I don't know the depth of the connections here, but Ariad has licenced some of the Verdine lab's stuff iccb.med.harvard.edu some background stuff on NFAT--oh, that stand for the nuclear factor of activated t-cells--I just learned that the other day, never know what it stood for! cmm.ucsd.edu cmm.ucsd.edu stanford.edu Remember...I am just a surfer. I don't get a lot of this stuff. Last night I pulled out the Abbey road book and did a little reading...very very humbling, and if I crash and burn by playing with biotech, well, at least I tried--you cant win in picking stocks if you don't play.